Hemorrhagic complications of emergency endovascular interventions
https://doi.org/10.30629/0023-2149-2024-102-4-315-322
Abstract
The article provides a systematic review of data from domestic and international literature on the issue of hemorrhagic complications that can occur during emergency endovascular interventions. It provides a generalized classifi cation of these complications and highlights the frequency of major and minor hemorrhages in diff erent locations, depending on their underlying cause. Various factors, causes, and mechanisms related to the development of hemorrhaging are discussed, including those associated with surgical access, vessel dissection, rupture, anticoagulation, anti-platelet therapy, and thrombolysis. Methods for preventing and treating these complications following endovascular procedures are also described in detail.
About the Authors
B. S. Sukovatykh
Kursk State Medical University
Russian Federation
Russian Federation
Boris S. Sukovatykh — Dr. of Sci. (Med.), Professor, Head of the Department of General Surgery
N. V. Bolomatov
Kursk City Emergency Hospital
Russian Federation
Russian Federation
Nikolay V. Bolomatov — Head of the Department of X-ray surgical methods of diagnosis and treatment
D. V. Sidorov
Oryol Regional Clinical Hospital
Russian Federation
Russian Federation
Dmitry V. Sidorov — Cand. of Sci. (Med.), doctor of the Department of X-ray surgical methods of diagnosis and treatment
M. B. Sukovatykh
Kursk State Medical University
Russian Federation
Russian Federation
Mikhail B. Sukovatykh — Cand. of Sci. (Med.), Associate Professor of the Department of General Surgery
References
1. Kirkina N. Yu., Kulichenkova Yu.S. Use of percutaneous coronary in the treatment ST elevation myocardial infarction. Clinical medicine and pharmacology. 2020;6(1):48–52. (In Russian).
2. Khorolets E.V., Shlyk S.V. Possibilities of reperfusion therapy for patients with acute myocardial infarction. Consilium Medicum. 2020;22(5):87–91. (In Russian).
3. Bessonov I.S., Kuznetsov V.A., Dyakova A.O. et. al. Percutaneous coronary interventions in patients with ST-elevation myocardial infarction: 10-years follow-up. Caridology. 2020;60(6):69–75. (In Russian).
4. Alekseeva Ya.V., Vyshlov E.V., Markov V.A. Deferred stent implantation in patients with ST-segment elevation myocardial infarction and massive coronary thrombosis. Siberian Medical Journal. 2018;33(2):16–20. (In Russian).
5. Andreushkov A.R. Comparison of results of early and delayed pci in patients with acs without ST segment elevation. system analysis of rct. Ural Medical Journal. 2020;7(190):46–49. (In Russian).
6. Téblick A., Vanderbruggen W., Vandendriessche T. Comparison of radial access versus femoral access with the use of a vascular closure device for the prevention of vascular complications and mortality after percutaneous coronary intervention. Acta Cardiol. 2018;73(3):241–247. DOI: 10.1080/00015385.2017.1363947. PMID: 28851255
7. Badri M., Shapiro T., Wang Y. et. al. Adoption of the transradial approach for percutaneous coronary intervention and rates of vascular complications following transfemoral procedures: Insights from NCDR. Catheter Cardiovasc. Interv. 2018;1:92(5):835–841. DOI: 10.1002/ccd.27490. PMID: 29359497
8. Andreev A.A., Olshansky M.S., Sukhochev E.N. Local hemostasis in endovascular interventions. Bulletin of experimental and clinical surgery. 2015;8(4):382–387. (In Russian).
9. Kireev K.A., Abaidulin R.Zh., Fokin A.A., Kireeva T.S. Clinical observation of hemorrhagic and thrombotic complications after percutaneous coronary intervention in myocardial infarction. Diagnostic and interventional radiology. 2015;9(2–1):72–78. (In Russian).
10. Roule V., Lemaitre A., Sabatier R., Lognoné T. et al. Transradial versus transfemoral approach for percutaneous coronary intervention in cardiogenic shock: A radial-fi rst centre experience and meta-analysis of published studies.. Arch. Cardiovasc. Dis. 2015;108(11):563–75. DOI: 10.1016/j.acvd.2015.06.005
11. Galimov O.V., Khanov V.O. Ibragimov T.R. Post-paracentesis hemostasis during endovascular surgery. Surgeon. 2018;11–12:77– 81. (In Russian).
12. Shevchenko Yu.L., Bolomatov N.V., Viller A.G., Harpunov V.F. Treatment of post-functional pulsating hematomas. International Journal of interventional cardioangiology. 2013;35:88a. (In Russian).
13. Vogiatzis I., Sdogkos E., Aidinis A. et al. Spontaneous dissection of the coronary vessels. epidemiological and coronary angiographic study. Mater Sociomed. 2019;31(3):177–180. DOI:10.5455/msm.2019;31:177-180
14. Sahu K.K., Mishra A.K., George S.V. et al. Managing retroperitoneal hematoma: Associated complexities and its challenges. Am. J. Emerg. Med. 2020;38(9):1957–1958. DOI: 10.1016/j.ajem.2020.02.003
15. Shah S.R., Alweis R. Acute coronary artery dissection: a review of the literature and current evidence. Cardiol. Rev. 2018;26(5):274– 276. DOI: 10.1097/CRD.0000000000000186
16. Yamamoto K., Sakakura K., Momomura Sh.-I. et al. Conservative management of severe coronary artery hematoma and dissection following stent implantation. Cardiovasc. Revasc. Med. 2019;20(4):347–350. DOI: 10.1016/j.carrev.2018.04.019
17. Mayngart S.V., Grechishkin A.A., Pakholkov A.N. Case of the successful treatment of antero-retrograde dissection of the left main coronary artery after percutaneous coronary intervention on left anterior descending artery with the stent implantation. Russian journal of Endovascular surgery. 2016;3 (4):45–51. (In Russian).
18. Tlegenova ZH.SH., Zholdin B.K, Kurmanalina G.L. Spontaneous coronary artery dissection: literature review and case report. 1 West Kazakhstan Marat Ospanov Medical University. Aktobe, Kazakhstan. 2020;62(1):86–92. (In Russian)
19. Verlaeckt E., Van de Bruaene L., Coeman M. et al. Spontaneous coronary artery dissection in a patient with hereditary polycystic kidney disease and a recent liver transplant: a case report. Eur. Heart J. Case Rep. ed. Ghanem A. et al. 2019;3(4):1–5. DOI:10.1093/ehjcr/ytz216
20. Luong C., Starovoytov A., Heydari M. et al. Clinical presentation of patients with spontaneous coronary artery dissection: clinical presentation of patients with SCAD. Catheter. Cardiovasc. Interv. 2017;89(7):1149–1154. DOI: 10.1002/ccd.26977
21. Hayes S.N., Kim E.S., Saw J. et al. Spontaneous coronary artery dissection: current state of the science: a scientifi c statement from the American Heart Association. Circulation. 2018;137(19):523–557. DOI: 10.1161/CIR.0000000000000564
22. Urasyanandana K., Songsang D., Aurboonyawat T. et. al. Treatment outcomes in cerebral artery dissection and literature review. Interv. Neuroradiol. 2018;24(3):254–262. DOI: 10.1177/1591019918755692
23. Iwamoto T., Oyama N., Kitano T.et al. Spontaneous dissection of both vertebral arteries diagnosed with three-dimensional t1-weighted image. J. Stroke Cerebrovasc. Dis. 2019;28(6):e71–e72. DOI: 10.1016/j.jstrokecerebrovasdis.2019.02.035
24. Hensler J., Jensen-Kondering U., Ulmer S. Spontaneous dissections of the anterior cerebral artery: a meta-analysis of the literature and three recent cases. Neuroradiology. 2016;58(10):997–1004. DOI: 10.1007/s00234-016-1731-9
25. Anadure R.K., Mohimen A., Saxena R. et al. A study on the clinical and angiographic spectrum of spontaneous extracranial dissections in the cerebral vasculature. J. Neurosci. Rural. Pract. 2018;9(3):344– 349. DOI: 10.4103/jnrp.jnrp_540_17
26. Sporns P.B., Niederstadt T., Heindel W. et al. Imaging of spontaneous and traumatic cervical artery dissection : comparison of typical ct angiographic features. Clin. Neuroradiol. 2019;29(2):269–275. DOI: 10.1007/s00062-018-0666-4
27. Ikeda H., Sano N., Torikoshi S. et al. Dissection of the vertebral artery fenestration limb presenting with occlusion after rupture. World Neurosurg. 2020;135:324–329. DOI: 10.1016/j.wneu.2019.12.133
28. Shibahara T., Yasaka M., Wakugawa Y. et al. Improvement and aggravation of spontaneous unruptured vertebral artery dissection. Cerebrovasc. Dis. Extra. 2017;7(3):153–164. DOI: 10.1159/000481442
29. Felice Pecoraro, Ettore Dinoto, David Pakeliani et al. Endovascular Treatment of Spontaneous Internal Carotid Artery Dissection with Proximal Embolic Protection Device. Ann. Vasc. Surg. 2020;66:667. e9–667.e14. DOI: 10.1016/j.avsg.2019.12.019
30. Cannon Ch.P., Gropper S., Bhatt D.L.et al. Design and rationale of the RE-DUAL PCI trial: a prospective, randomized, phase 3b study comparing the safety and effi cacy of dual antithrombotic therapy with dabigatran etexilate versus warfarin triple therapy in patients with nonvalvular atrial fi brillation who have undergone percutaneous coronary intervention with stenting. Clin. Cardiol. 2016;39(10):555– 564. DOI: 10.1002/clc.22572
31. Dahal Kh., Mosleh W., Almnajam M. et al. NOAC-Based sual therapy versus warfarin-based triple therapy after percutaneous coronary intervention or acute coronary syndrome in patients with atrial fi brillation: a systematic review and meta-analysis. Cardiovasc. Revasc. Med. 2020;21(10):1202–1208. DOI: 10.1016/j.carrev.2020.03.012
32. Sukovatykh B.S., Sereditsky A.V., Sukovatykh M.B. Endovascular surgery of deep vein thrombosis. Surgery. Journal named after N.I. Pirogov.2023; 2:79–85. (In Russian). DOI: 10.17116/hirurgia202302179
33. Khan S.U., Osman M., Khan-Dual M.U. et al. Versus triple therapy for atrial fi brillation after percutaneous coronary intervention: a systematic review and meta-analysis. Ann. Intern. Med. 2020;172(7):474–483. DOI: 10.7326/M19-3763
34. Ten Berg J.M., de Veer A., Oldgren J. et al. Switching of oral anticoagulation therapy after pci in patients with atrial fi brillation: The RE-DUAL PCI Trial Subanalysis. JACC Cardiovasc. Interv. 2019;12(23):2331–2341. DOI: 10.1016/j.jcin.2019.08.039
35. Bagur R., Jolly S.S. et al. Dual antiplatelet therapy after percutaneous coronary intervention. Circ. Cardiovasc. Interv. 2018;11(10):e007368. DOI: 10.1161/CIRCINTERVENTIONS.118.007368
36. Aaqib H Malik, Srikanth Yandrapalli, Suchith S Shetty et. al. Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention. Am. J. Cardiol. 2020;15;127:25–29. DOI: 10.1016/j.amjcard.2020.04.027
37. Dominick J. Angiolillo1 , Matthew J. Price Antiplatelet and Anticoagulation Therapy in Percutaneous Coronary Intervention. Interv. Cardiol. Clin. 2017;6(1):xi–xii. DOI: 10.1016/j.iccl.2016.10.001
38. Bedjaoui A., Allal K., Lounes M.S. et. al. Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention. Cardiovasc. J. Afr. 2019;30(1):45–51. DOI: 10.5830/CVJA-2018-063
39. Ahmed N Rgeeb , Hussein A Alsalkh , Ali Kadhim Radhi , Khalid Amber. Eff ect of Intravenous Abciximab on Coronary Flow Improvement After Re-vascularization in Primary Coronary Intervention and Short Term Impact. 2020 Aug;74(4):265 –269. DOI: 10.5455/medarh.2020.74.265-269.
40. Rgeeb A.N., Alsalkh H.A. et al. Eff ect of Intravenous Abciximab on coronary fl ow improvement after re-vascularization in primary coronary intervention and short term impact. Med. Arch. 2020;74(4):265– 269. DOI: 10.5455/medarh.2020.74.265-269.
41. Karathanos A., Lin Y., Dannenberg L. et al. Routine glycoprotein IIb/ IIIa inhibitor therapy in st-segment elevation myocardial infarction: a meta-analysis. Can. J. Cardiol. 2019;35(11):1576–1588. DOI: 10.1016/j.cjca.2019.05.003.
42. Dannenberg L., Wolff G., Naguib D.et al. Safety and effi cacy of Tirofi ban in STEMI-patients. Int. J. Cardiol. 2019;274:35–39. DOI: 10.1016/j.ijcard.2018.09.052
43. Fischer F., Buxy S., Kurz D.J.et al. Effi cacy and safety of abbreviated eptifi batide treatment in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am. J. Cardiol. 2021;15;139:15–21. DOI: 10.1016/j.amjcard.2020.09.054
44. Pevzner D.V., Staroverov I.I., Samko A.M. et. al. Glycoprotein IIb –IIIa antagonist monafram in primary angioplasty of patients with acute coronary syndrome without ST segment elevation. Caridology. 2010;50 (6):22–26. (In Russian).
45. Sukovatykh B.S., Sereditsky A.V., Muradyan V.F., Azarov A.M., Sukovatykh M.B., Lapinas A.A. Results of treatment of late proximal deep vein thrombosis by regional catheter thrombolysis. Surgery. Magazine named after N.I. Pirogov. 2023;(1):61–66. (In Russian). DOI: 10.17116/hirurgia202301161
46. Pu J., Ding S., Ge H. et al. Effi cacy and safety of a pharmaco-invasive strategy with half-dose alteplase versus primary angioplasty in st-segment-elevation myocardial infarction: EARLY-MYO Trial (Early routine catheterization after alteplase fi brinolysis versus primary PCI in acute ST-segment-elevation myocardial infarction). Circulation. 2017;136(16):1462–1473. DOI: 10.1161/CIRCULATIONAHA.117.030582
47. Kocayigit I., Yaylaci S., Osken A., Aydın E. et al. Comparison of effects of thrombolytic therapy and primary percutaneous coronary intervention in elderly patients with acute ST-segment elevation myocardial infarction on in-hospital, six-month, and one-year mortality. Arch. Med. Sci. Atheroscler. Dis. 2019;4:e82–e88. DOI: 10.5114/amsad.2019.85378. eCollection 2019
48. Vyshlov E.V., Avetisyan V.Y., Kuzeleva E.A. et al. In-hospital and long-term results of delayed percutaneous coronary intervention after successful thrombolytic therapy in elderly patients with acute myocardial infarction. Adv. Gerontol. 2018;31(1):121–125.
49. Bawaskar H.S., Bawaskar P.H., Bawaskar P.H. Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital.. J. Family Med. Prim. Care. 2019;8(1):62–71. DOI: 10.4103/jfmpc.jfmpc_297_18
50. Soleimani M., Soleimani A., Roohafza H. et al. The comparison of procedural and clinical outcomes of thrombolytic-facilitated and primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction (STEMI): Findings from PROVE/ACS study. ARYA Atheroscler. 2020;16(3):123–129. DOI: 10.22122/arya.v16i3.1869
51. Hathi V., Anadkat M. A Comparative study of in-hospital outcome of patients with ST-segment elevation myocardial infarction with and without diabetes mellitus, after thrombolytic therapy; in government hospital of Rajkot, Gujarat, India. J. Assoc. Physicians India. 2017;65(11):22–25.
52. Joy E.R., Kurian J., Gale C.P. Comparative eff ectiveness of primary PCI versus fi brinolytic therapy for ST-еlevation myocardial infarction: a review of the literature. J. Comp. Eff . Res. 2016;5(2):217–26. DOI: 10.2217/cer-2015-0011
53. Mallidi J.R., Robinson P., Visintainer P.F. et al. Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study. Catheter. Cardiovasc. Interv. 2017;15;90(6):898–904. DOI: 10.1002/ccd.27042
54. Zia-Behbahani M., Hossein H., Kojuri J. et al. Tenecteplase Versus Reteplase in Acute Myocardial Infarction: A Network MetaAnalysis of Randomized Clinical Trials. Iran. J. Pharm. Res. 2019;18(3):1622–1631. DOI: 10.22037/ijpr.2019.1100743
55. Armstrong PW, Bogaerts K, Welsh R. et. al. The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older STelevation myocardial infarction patients. Am. Heart J. 2020;226:140– 146. DO : 10.1016/j.ahj.2020.04.029
Review
For citations:
Sukovatykh B.S., Bolomatov N.V., Sidorov D.V., Sukovatykh M.B. Hemorrhagic complications of emergency endovascular interventions. Clinical Medicine (Russian Journal). 2024;102(4):315-322. (In Russ.) https://doi.org/10.30629/0023-2149-2024-102-4-315-322
Views:
379
Email this article 